Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

2021 Genitourinary Cancers Symposium

Videos
News
New data from the phase 3 CLEAR trial demonstrate significant improvement in progression free survival and overall survival versus standard of care in advanced renal cell carcinoma
New data from the phase 3 CLEAR trial demonstrate significant improvement in progression free survival and overall...
Immunotherapy combo improves survival in advanced kidney cancer
Immunotherapy combo improves survival in advanced kidney cancer
Cabozantinib most effective treatment for metastatic papillary kidney cancer
Cabozantinib most effective treatment for metastatic papillary kidney cancer
ASCO GU 2021: Immunotherapy nivolumab doubles disease-free survival in a type of high-risk urothelial carcinoma
ASCO GU 2021: Immunotherapy nivolumab doubles disease-free survival in a type of high-risk urothelial carcinoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation